Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Apr 11, 2016

Mylan Launches First and Only Available Intermediate Dosage Strengths of Generic Lopressor® Tablets 37.5 mg and 75 mg

Apr 06, 2016

Mylan Launches Generic Epivir® Tablets

Mar 28, 2016

Mylan Launches Generic Ultram® Extended-Release Tablets

Mar 04, 2016

Mylan to Present at the Barclays Global Healthcare Conference

Mar 04, 2016

Mylan to Present at the Raymond James 37th Annual Institutional Investors Conference

Feb 22, 2016

Mylan CEO Heather Bresch Elected Chair of Generic Pharmaceutical Association

Feb 22, 2016

Mylan Appoints Anthony Mauro Chief Commercial Officer

Feb 19, 2016

Mylan's ANDA for Generic Advair Diskus® Accepted for Filing by FDA

Feb 16, 2016

Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2015

Feb 10, 2016

Mylan Full Year Adjusted Diluted EPS Up 21% to $4.30

Pagination

First page
Previous page
…
Page 26
Page 27
Page 28
Page 29
Current page 30
Page 31
Page 32
Page 33
Page 34
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.